首页> 外文期刊>Translational psychiatry. >Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach
【24h】

Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach

机译:22q11.2缺失相关精神分裂症的风险基因组和途径:系谱分子方法

获取原文
           

摘要

The 22q11.2 deletion is a strong, but insufficient, "first hit" genetic risk factor for schizophrenia (SZ). We attempted to identify "second hits" from the entire genome in a unique multiplex 22q11.2 deletion syndrome (DS) family. Bioinformatic analysis of whole-exome sequencing and comparative-genomic hybridization array identified de novo and inherited, rare and damaging variants, including copy number variations, outside the 22q11.2 region. A specific 22q11.2-haplotype was associated with psychosis. The interaction of the identified "second hits" with the 22q11.2 haploinsufficiency may affect neurodevelopmental processes, including neuron projection, cytoskeleton activity, and histone modification in 22q11.2DS-ralated psychosis. A larger load of variants, involved in neurodevelopment, in combination with additional molecular events that affect sensory perception, olfactory transduction and G-protein-coupled receptor signaling may account for the development of 22q11.2DS-related SZ. Comprehensive analysis of multiplex families is a promising approach to the elucidation of the molecular pathophysiology of 22q11.2DS-related SZ with potential relevance to treatment.
机译:22q11.2缺失是精神分裂症(SZ)的强大但不足的“首发”遗传危险因素。我们试图从独特的多重22q11.2缺失综合症(DS)家族的整个基因组中识别出“第二击”。全外显子组测序和比较基因组杂交阵列的生物信息学分析确定了从头和遗传的,罕见的和破坏性变异,包括拷贝数变异,位于22q11.2区域之外。特定的22q11.2单倍型与精神病有关。识别出的“第二击”与22q11.2单倍剂量不足的相互作用可能会影响神经发育过程,包括神经元投射,细胞骨架活性和22q11.2DS引起的精神病的组蛋白修饰。大量参与神经发育的变体,再加上影响感官知觉,嗅觉转导和G蛋白偶联受体信号转导的其他分子事件,可能是22q11.2DS相关SZ发生的原因。多重家族的综合分析是阐明22q11.2DS相关性SZ的分子病理生理学的一种有前途的方法,可能与治疗有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号